September 6, 2016 08:01 AM EDT
R&D

Af­ter land­ing a $354M pay­out, Medi­va­tion CEO David Hung doesn’t over­look his 2016 bonus

John Carroll

Editor & Founder

It’s been a very good year at Medi­va­tion, num­bers wise. So now that CEO David Hung has com­plet­ed his $14 bil­lion deal to sell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Trump’s sci­ence crack­down hits rare dis­ease re­search: ‘We need to sit down with Elon Musk’

At least sev­en drug­mak­ers say they will par­tic­i­pate in round two of IRA ne­go­ti­a­tions 

Ex­clu­sive: In­fec­tious dis­ease doc­tors con­sid­er 'mi­ni-ACIP' if RFK erodes CDC vac­cine pan­el

Lil­ly joins mol­e­c­u­lar glue field with Mag­net deal worth up to $1.25B

Paci­ra ab­sorbs GQ Bio for $32M; Lay­offs at BMS, Ei­sai and CRISPR Ther­a­peu­tics

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times